Consent of Independent Auditor
We consent to the use in this Amendment No. 1 to Registration Statement (No 333-227547) on Form S-4 of Ovascience, Inc. of our report dated May 4, 2018, relating to the financial statements of Millendo Therapeutics SAS (formerly named Alizé Pharma), appearing in the Prospectus, which is part of this Registration Statement.
| Lyon, November 1, 2018 |
|
|
| Le Commissaire aux comptes |
|
|
| /s/ RSM Rhône-Alpes |
|
|
| Gaël Dhalluin |
| Partner |